Related Experiment Video
Updated: Jun 4, 2025
07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
73
The functional role of LncRNA HOXA-AS2 in multiple human cancers
Mohadeseh Khoshandam1, Nikolaos Sideris2, Amirhossein Ahmadieh-Yazdi3
1Department of Reproductive Biology, Academic Center for Education, Culture and Research, Qom Branch, Qom, Iran.
Pathology, Research and Practice
|January 5, 2025
Summary
Long non-coding RNA HOXA-AS2 acts as an oncogene in numerous cancers. Silencing HOXA-AS2 inhibits tumor growth and promotes apoptosis, highlighting its potential as a diagnostic and therapeutic target for various malignancies.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are crucial regulators of cellular processes.
- Aberrant lncRNA expression is linked to various human cancers.
- HOXA-AS2 is a lncRNA with oncogenic roles in multiple malignancies.
Purpose of the Study:
- To review the structure, biological functions, and expression of HOXA-AS2.
- To explore the regulatory mechanisms of HOXA-AS2 in cancer.
- To assess the diagnostic and therapeutic potential of HOXA-AS2.
Main Methods:
- Literature review of recent research on HOXA-AS2.
- Analysis of HOXA-AS2's role in cell proliferation, apoptosis, migration, and invasion.
- Investigation of HOXA-AS2's regulatory pathways and interactions.
Main Results:
- HOXA-AS2 is overexpressed in various cancers and correlates with tumor size and stage.
- Silencing HOXA-AS2 suppresses tumor proliferation and induces apoptosis.
- HOXA-AS2 regulates cancer progression via EMT, Bcl-2, c-Myc, AKT-MMP signaling, EZH2, LSD1, and ceRNA networks.
Conclusions:
- HOXA-AS2 is a potential tumor marker for cancer diagnosis and prognosis.
- Targeting HOXA-AS2 presents a promising therapeutic strategy for cancer treatment.
- Further research into HOXA-AS2's mechanisms can lead to novel cancer therapies.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
03:18Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
01:12Loss of Tumor Suppressor Gene Functions
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
01:32RNA Splicing
56.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K